36 results
Thumbnail

D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab

Thumbnail

D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab

Thumbnail

D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis

Thumbnail

D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic

Thumbnail

D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates

Thumbnail

D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab

Thumbnail

D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results

Thumbnail

D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years

Thumbnail

D1.369 - Characteristics of patients with severe asthma undergoing biological treatment at a reference center

Thumbnail

D1.371 - Dupilumab for the treatment of refractory severe chronic spontaneous urticaria

Thumbnail

D2.100 - The usefulness of the forced oscillation technique in the diagnosis of bronchial asthma in seniors

Thumbnail

D2.111 - Wheeze phenotypes in infants whose mothers have asthma

Thumbnail

D2.99 - A mechanosensitive cytoskeleton protein talin2 involved in asthma pathogenesis

Thumbnail

D2.102 - Adult Gut Microbiota and Metabolomics in Different Phenotypes of Asthma

Thumbnail

D2.103 - Exploring association between lung function, asthma and epigenetic predisposition to obesity

Thumbnail

D2.104 - Dissecting the molecular mechanisms underlying TSLP-driven non-type 2 inflammatory responses in severe asthma

Thumbnail

D2.105 - Clinical remission of severe asthma: 5-year follow-up

Thumbnail

D2.106 - Molecular Clustering Using microRNA Expression Profiles in Pediatric Asthma Reveals Differential Corticosteroid Responsiveness

Thumbnail

D2.107 - Effect of n-3 long-chain polyunsaturated fatty acid and vitamin D supplementation on human lung organoids

Thumbnail

D2.108 - Real-life experience after 6 months with Tezepelumab in specialized asthma units across northern Spain